

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 4.97886501 |
| 2 | maturation of 5.8S rRNA (GO:0000460) | 4.72181606 |
| 3 | ribosome assembly (GO:0042255) | 4.39071587 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.39024180 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 4.39024180 |
| 6 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.37659826 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.27991551 |
| 8 | chaperone-mediated protein transport (GO:0072321) | 4.25853517 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.19603724 |
| 10 | rRNA modification (GO:0000154) | 4.16257037 |
| 11 | DNA double-strand break processing (GO:0000729) | 4.04561359 |
| 12 | pseudouridine synthesis (GO:0001522) | 4.00136768 |
| 13 | cullin deneddylation (GO:0010388) | 3.93518512 |
| 14 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.92969302 |
| 15 | protein neddylation (GO:0045116) | 3.91379662 |
| 16 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.89956034 |
| 17 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.88615575 |
| 18 | negative regulation of ligase activity (GO:0051352) | 3.88615575 |
| 19 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.88433647 |
| 20 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.86552737 |
| 21 | DNA deamination (GO:0045006) | 3.86270227 |
| 22 | ribosomal large subunit biogenesis (GO:0042273) | 3.84583175 |
| 23 | protein deneddylation (GO:0000338) | 3.81726103 |
| 24 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.80700049 |
| 25 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.75082166 |
| 26 | rRNA methylation (GO:0031167) | 3.74864780 |
| 27 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.72253436 |
| 28 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.72253436 |
| 29 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.72253436 |
| 30 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.71359570 |
| 31 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.71359570 |
| 32 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.70031444 |
| 33 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.70031444 |
| 34 | isotype switching (GO:0045190) | 3.70031444 |
| 35 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.68356565 |
| 36 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.68356565 |
| 37 | rRNA processing (GO:0006364) | 3.67313988 |
| 38 | IMP biosynthetic process (GO:0006188) | 3.62590123 |
| 39 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.57581300 |
| 40 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.57581300 |
| 41 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.57030155 |
| 42 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.55484129 |
| 43 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.55217536 |
| 44 | termination of RNA polymerase III transcription (GO:0006386) | 3.55217536 |
| 45 | rRNA metabolic process (GO:0016072) | 3.54877869 |
| 46 | nucleobase biosynthetic process (GO:0046112) | 3.51136526 |
| 47 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.50414780 |
| 48 | chromatin remodeling at centromere (GO:0031055) | 3.48255458 |
| 49 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.46945035 |
| 50 | DNA damage response, detection of DNA damage (GO:0042769) | 3.43436690 |
| 51 | maturation of SSU-rRNA (GO:0030490) | 3.41664104 |
| 52 | amino acid activation (GO:0043038) | 3.40298378 |
| 53 | tRNA aminoacylation (GO:0043039) | 3.40298378 |
| 54 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.39403178 |
| 55 | CENP-A containing nucleosome assembly (GO:0034080) | 3.36982538 |
| 56 | tRNA aminoacylation for protein translation (GO:0006418) | 3.33984089 |
| 57 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.33735215 |
| 58 | DNA replication checkpoint (GO:0000076) | 3.32407948 |
| 59 | purine nucleobase biosynthetic process (GO:0009113) | 3.30321755 |
| 60 | tRNA metabolic process (GO:0006399) | 3.27964594 |
| 61 | ribosome biogenesis (GO:0042254) | 3.27016756 |
| 62 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.26841476 |
| 63 | respiratory chain complex IV assembly (GO:0008535) | 3.26832682 |
| 64 | GTP biosynthetic process (GO:0006183) | 3.24680680 |
| 65 | positive regulation of ligase activity (GO:0051351) | 3.24096489 |
| 66 | IMP metabolic process (GO:0046040) | 3.23978775 |
| 67 | protein targeting to mitochondrion (GO:0006626) | 3.23928912 |
| 68 | protein complex biogenesis (GO:0070271) | 3.23502517 |
| 69 | tRNA processing (GO:0008033) | 3.20265161 |
| 70 | peptidyl-histidine modification (GO:0018202) | 3.19434292 |
| 71 | termination of RNA polymerase I transcription (GO:0006363) | 3.17375999 |
| 72 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.16917766 |
| 73 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.15619333 |
| 74 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.15454742 |
| 75 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.15454742 |
| 76 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.14490139 |
| 77 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.14087237 |
| 78 | translation (GO:0006412) | 3.13545295 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.13076776 |
| 80 | histone mRNA metabolic process (GO:0008334) | 3.11506270 |
| 81 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.10081500 |
| 82 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.10081500 |
| 83 | NADH dehydrogenase complex assembly (GO:0010257) | 3.10081500 |
| 84 | cellular component biogenesis (GO:0044085) | 3.06700685 |
| 85 | transcription from mitochondrial promoter (GO:0006390) | 3.06448819 |
| 86 | ncRNA metabolic process (GO:0034660) | 3.05728703 |
| 87 | CTP biosynthetic process (GO:0006241) | 3.05434826 |
| 88 | CTP metabolic process (GO:0046036) | 3.05434826 |
| 89 | regulation of immunoglobulin secretion (GO:0051023) | 3.05427270 |
| 90 | respiratory electron transport chain (GO:0022904) | 3.04349734 |
| 91 | protein localization to mitochondrion (GO:0070585) | 3.02560216 |
| 92 | ncRNA processing (GO:0034470) | 3.02539561 |
| 93 | ribosomal small subunit assembly (GO:0000028) | 3.02402358 |
| 94 | electron transport chain (GO:0022900) | 3.01867376 |
| 95 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.01618667 |
| 96 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.00972622 |
| 97 | UTP biosynthetic process (GO:0006228) | 3.00062613 |
| 98 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.99952567 |
| 99 | establishment of integrated proviral latency (GO:0075713) | 2.98550741 |
| 100 | positive regulation of cell cycle arrest (GO:0071158) | 2.98472815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.51741513 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.89255555 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.55400589 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.24641794 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.70607977 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.42003468 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.18066125 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.15321306 |
| 9 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.02807282 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.91416084 |
| 11 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.83383705 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.82301836 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.80241669 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.75882606 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64868461 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.52807551 |
| 17 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.51248875 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.43556841 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.41368017 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.34436499 |
| 21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.30522877 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25888479 |
| 23 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.18534807 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.12839814 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.12791303 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12296993 |
| 27 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.02801574 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01643382 |
| 29 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.99103761 |
| 30 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.97768045 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.96169396 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.89326509 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87766678 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86920713 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.82789645 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.81217392 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.78995824 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.77798802 |
| 39 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.67800607 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63434725 |
| 41 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63393204 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62766594 |
| 43 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.62574892 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58670583 |
| 45 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.56643077 |
| 46 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.53670910 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.50807363 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.49444302 |
| 49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.48400468 |
| 50 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39704418 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34925148 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33221327 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30466881 |
| 54 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.27889010 |
| 55 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27184449 |
| 56 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.27161031 |
| 57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.23662993 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23497131 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22858995 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22266190 |
| 61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20320647 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18409547 |
| 63 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16515137 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14865416 |
| 65 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.11958828 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10530847 |
| 67 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07515047 |
| 68 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07259086 |
| 69 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05529409 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02650826 |
| 71 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00126129 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98913763 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98715343 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.98255511 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.97209302 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96805415 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96640907 |
| 78 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93279223 |
| 79 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90531546 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88561587 |
| 81 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.87976071 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.84287793 |
| 83 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.84287793 |
| 84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83617023 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83019901 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.80513262 |
| 87 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.80448163 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79448346 |
| 89 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.79329752 |
| 90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.78365711 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76929940 |
| 92 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.76857686 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76791814 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75555488 |
| 95 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.75249735 |
| 96 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.73938698 |
| 97 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.73100458 |
| 98 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.72274984 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.72274984 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.71879805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.76486831 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.72405477 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.60291993 |
| 4 | MP0008058_abnormal_DNA_repair | 3.46465552 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.29580606 |
| 6 | MP0008877_abnormal_DNA_methylation | 3.17957409 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.90709942 |
| 8 | MP0008057_abnormal_DNA_replication | 2.88763906 |
| 9 | MP0003786_premature_aging | 2.73545906 |
| 10 | MP0001873_stomach_inflammation | 2.46135046 |
| 11 | MP0006072_abnormal_retinal_apoptosis | 2.40842049 |
| 12 | MP0005671_abnormal_response_to | 2.37652559 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.35806071 |
| 14 | MP0003186_abnormal_redox_activity | 2.23980202 |
| 15 | MP0003077_abnormal_cell_cycle | 2.19309528 |
| 16 | MP0009697_abnormal_copulation | 2.14097411 |
| 17 | MP0003718_maternal_effect | 2.01382622 |
| 18 | MP0008932_abnormal_embryonic_tissue | 1.86768239 |
| 19 | MP0002102_abnormal_ear_morphology | 1.85539789 |
| 20 | MP0008872_abnormal_physiological_respon | 1.85530883 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.84109821 |
| 22 | MP0001529_abnormal_vocalization | 1.83357785 |
| 23 | MP0008007_abnormal_cellular_replicative | 1.83241428 |
| 24 | MP0004147_increased_porphyrin_level | 1.76930011 |
| 25 | MP0002006_tumorigenesis | 1.71370172 |
| 26 | MP0000685_abnormal_immune_system | 1.66038458 |
| 27 | MP0001790_abnormal_immune_system | 1.65984034 |
| 28 | MP0005387_immune_system_phenotype | 1.65984034 |
| 29 | MP0009785_altered_susceptibility_to | 1.64257505 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.63423614 |
| 31 | MP0002163_abnormal_gland_morphology | 1.62754301 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.61549385 |
| 33 | MP0003195_calcinosis | 1.57324856 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.53985625 |
| 35 | MP0001661_extended_life_span | 1.45353714 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.44943627 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.39943596 |
| 38 | MP0003890_abnormal_embryonic-extraembry | 1.38972928 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.32816182 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.25247701 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.25208277 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.24083447 |
| 43 | MP0003567_abnormal_fetal_cardiomyocyte | 1.22200969 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.19540559 |
| 45 | MP0000516_abnormal_urinary_system | 1.16068142 |
| 46 | MP0005367_renal/urinary_system_phenotyp | 1.16068142 |
| 47 | MP0001730_embryonic_growth_arrest | 1.14414234 |
| 48 | MP0001800_abnormal_humoral_immune | 1.11397992 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.10303037 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.09497511 |
| 51 | MP0000490_abnormal_crypts_of | 1.07897514 |
| 52 | MP0001293_anophthalmia | 1.07494369 |
| 53 | MP0003941_abnormal_skin_development | 1.05165341 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.03880257 |
| 55 | MP0006054_spinal_hemorrhage | 1.02637066 |
| 56 | MP0001853_heart_inflammation | 1.01746189 |
| 57 | MP0001881_abnormal_mammary_gland | 1.01679167 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.01477981 |
| 59 | MP0001188_hyperpigmentation | 1.00936241 |
| 60 | MP0004215_abnormal_myocardial_fiber | 0.99036194 |
| 61 | MP0005332_abnormal_amino_acid | 0.98148464 |
| 62 | MP0009379_abnormal_foot_pigmentation | 0.96498252 |
| 63 | MP0003646_muscle_fatigue | 0.94964423 |
| 64 | MP0002210_abnormal_sex_determination | 0.94739449 |
| 65 | MP0010307_abnormal_tumor_latency | 0.91826971 |
| 66 | MP0002751_abnormal_autonomic_nervous | 0.91507774 |
| 67 | MP0008873_increased_physiological_sensi | 0.89343803 |
| 68 | MP0000427_abnormal_hair_cycle | 0.88258151 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.87139684 |
| 70 | MP0005408_hypopigmentation | 0.86580436 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 0.86220637 |
| 72 | MP0003936_abnormal_reproductive_system | 0.85005131 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 0.82766535 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 0.82146086 |
| 75 | MP0005389_reproductive_system_phenotype | 0.81975229 |
| 76 | MP0001984_abnormal_olfaction | 0.81930610 |
| 77 | MP0001929_abnormal_gametogenesis | 0.80942722 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 0.80934873 |
| 79 | MP0001727_abnormal_embryo_implantation | 0.80559892 |
| 80 | MP0005000_abnormal_immune_tolerance | 0.79723384 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.79039791 |
| 82 | MP0003937_abnormal_limbs/digits/tail_de | 0.78122772 |
| 83 | MP0001919_abnormal_reproductive_system | 0.77451535 |
| 84 | MP0000313_abnormal_cell_death | 0.77281563 |
| 85 | MP0000350_abnormal_cell_proliferation | 0.76164942 |
| 86 | MP0005410_abnormal_fertilization | 0.75183594 |
| 87 | MP0008995_early_reproductive_senescence | 0.75028431 |
| 88 | MP0002396_abnormal_hematopoietic_system | 0.74585603 |
| 89 | MP0000653_abnormal_sex_gland | 0.74101504 |
| 90 | MP0005253_abnormal_eye_physiology | 0.73995092 |
| 91 | MP0002938_white_spotting | 0.73523689 |
| 92 | MP0001145_abnormal_male_reproductive | 0.72969226 |
| 93 | MP0009764_decreased_sensitivity_to | 0.72566579 |
| 94 | MP0001697_abnormal_embryo_size | 0.72536863 |
| 95 | MP0001119_abnormal_female_reproductive | 0.71768555 |
| 96 | MP0000689_abnormal_spleen_morphology | 0.71531088 |
| 97 | MP0002736_abnormal_nociception_after | 0.71447487 |
| 98 | MP0000627_abnormal_mammary_gland | 0.70915223 |
| 99 | MP0001286_abnormal_eye_development | 0.70597421 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.70349610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.12557323 |
| 2 | Increased hepatocellular lipid droplets (HP:0006565) | 4.66438780 |
| 3 | Acute encephalopathy (HP:0006846) | 4.51744799 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.45904421 |
| 5 | Increased CSF lactate (HP:0002490) | 4.34446676 |
| 6 | Mitochondrial inheritance (HP:0001427) | 4.29687006 |
| 7 | Progressive macrocephaly (HP:0004481) | 4.25701729 |
| 8 | Lipid accumulation in hepatocytes (HP:0006561) | 4.24799239 |
| 9 | Congenital, generalized hypertrichosis (HP:0004540) | 3.72550332 |
| 10 | Stomatitis (HP:0010280) | 3.70978194 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.51440250 |
| 12 | 3-Methylglutaconic aciduria (HP:0003535) | 3.48895813 |
| 13 | Cerebral edema (HP:0002181) | 3.45207533 |
| 14 | Renal Fanconi syndrome (HP:0001994) | 3.35706056 |
| 15 | Increased serum lactate (HP:0002151) | 3.29844586 |
| 16 | Exertional dyspnea (HP:0002875) | 3.27042869 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.12176953 |
| 18 | Hepatic necrosis (HP:0002605) | 3.11005396 |
| 19 | Increased intramyocellular lipid droplets (HP:0012240) | 2.94835152 |
| 20 | Abnormality of alanine metabolism (HP:0010916) | 2.89277151 |
| 21 | Hyperalaninemia (HP:0003348) | 2.89277151 |
| 22 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.89277151 |
| 23 | Abnormality of the pons (HP:0007361) | 2.88850319 |
| 24 | Abnormality of the anterior horn cell (HP:0006802) | 2.81053768 |
| 25 | Degeneration of anterior horn cells (HP:0002398) | 2.81053768 |
| 26 | Leukodystrophy (HP:0002415) | 2.78587082 |
| 27 | Colon cancer (HP:0003003) | 2.77583316 |
| 28 | Lactic acidosis (HP:0003128) | 2.75556679 |
| 29 | IgG deficiency (HP:0004315) | 2.72739144 |
| 30 | Hypoplasia of the pons (HP:0012110) | 2.68259180 |
| 31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.64506906 |
| 32 | Methylmalonic acidemia (HP:0002912) | 2.63097820 |
| 33 | Respiratory difficulties (HP:0002880) | 2.62578402 |
| 34 | Optic disc pallor (HP:0000543) | 2.54636279 |
| 35 | Exercise intolerance (HP:0003546) | 2.51561023 |
| 36 | Meckel diverticulum (HP:0002245) | 2.49228784 |
| 37 | Abnormality of the labia minora (HP:0012880) | 2.46319512 |
| 38 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.43889295 |
| 39 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.43889295 |
| 40 | Increased serum pyruvate (HP:0003542) | 2.39123019 |
| 41 | Abnormality of the ileum (HP:0001549) | 2.36797421 |
| 42 | Respiratory failure (HP:0002878) | 2.36547938 |
| 43 | Aplastic anemia (HP:0001915) | 2.34167040 |
| 44 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.33848785 |
| 45 | Increased muscle lipid content (HP:0009058) | 2.31498883 |
| 46 | Abnormality of the preputium (HP:0100587) | 2.29924098 |
| 47 | Multiple enchondromatosis (HP:0005701) | 2.29629035 |
| 48 | Microvesicular hepatic steatosis (HP:0001414) | 2.25805772 |
| 49 | Abnormality of chromosome stability (HP:0003220) | 2.21252540 |
| 50 | Lethargy (HP:0001254) | 2.16932743 |
| 51 | Hypoproteinemia (HP:0003075) | 2.15170613 |
| 52 | Hypothermia (HP:0002045) | 2.13388436 |
| 53 | Abnormality of methionine metabolism (HP:0010901) | 2.11906838 |
| 54 | Absent thumb (HP:0009777) | 2.11006921 |
| 55 | Abnormality of glycolysis (HP:0004366) | 2.09335078 |
| 56 | Abnormality of midbrain morphology (HP:0002418) | 2.08240192 |
| 57 | Molar tooth sign on MRI (HP:0002419) | 2.08240192 |
| 58 | Pancreatic cysts (HP:0001737) | 2.07156099 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.06939541 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.05536336 |
| 61 | Chromsome breakage (HP:0040012) | 2.04067370 |
| 62 | Pancytopenia (HP:0001876) | 2.02720748 |
| 63 | Bile duct proliferation (HP:0001408) | 1.98999361 |
| 64 | Abnormal biliary tract physiology (HP:0012439) | 1.98999361 |
| 65 | Cleft eyelid (HP:0000625) | 1.96634107 |
| 66 | Testicular atrophy (HP:0000029) | 1.96043204 |
| 67 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.92317091 |
| 68 | Abnormality of renal resorption (HP:0011038) | 1.91588645 |
| 69 | Methylmalonic aciduria (HP:0012120) | 1.89801481 |
| 70 | Megaloblastic anemia (HP:0001889) | 1.88656485 |
| 71 | Palpitations (HP:0001962) | 1.88309929 |
| 72 | Abolished electroretinogram (ERG) (HP:0000550) | 1.88144104 |
| 73 | Horseshoe kidney (HP:0000085) | 1.84399731 |
| 74 | Cerebral hypomyelination (HP:0006808) | 1.83213487 |
| 75 | Reticulocytopenia (HP:0001896) | 1.82805867 |
| 76 | Increased IgM level (HP:0003496) | 1.81941792 |
| 77 | Type I transferrin isoform profile (HP:0003642) | 1.81897443 |
| 78 | Macrocytic anemia (HP:0001972) | 1.79107051 |
| 79 | Small intestinal stenosis (HP:0012848) | 1.79031449 |
| 80 | Duodenal stenosis (HP:0100867) | 1.79031449 |
| 81 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.78995539 |
| 82 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.76893775 |
| 83 | Progressive microcephaly (HP:0000253) | 1.76483573 |
| 84 | Abnormality of vitamin B metabolism (HP:0004340) | 1.76382566 |
| 85 | Congenital stationary night blindness (HP:0007642) | 1.74739892 |
| 86 | Amniotic constriction ring (HP:0009775) | 1.74682046 |
| 87 | Abnormality of placental membranes (HP:0011409) | 1.74682046 |
| 88 | Birth length less than 3rd percentile (HP:0003561) | 1.74457411 |
| 89 | Sensory axonal neuropathy (HP:0003390) | 1.74032622 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.72989438 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 1.71497408 |
| 92 | Glycosuria (HP:0003076) | 1.71497408 |
| 93 | Hyperphosphaturia (HP:0003109) | 1.68716601 |
| 94 | Oral leukoplakia (HP:0002745) | 1.68349686 |
| 95 | CNS demyelination (HP:0007305) | 1.67837492 |
| 96 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.66927524 |
| 97 | Abnormality of the duodenum (HP:0002246) | 1.66581477 |
| 98 | Clubbing of toes (HP:0100760) | 1.66281574 |
| 99 | Sparse eyelashes (HP:0000653) | 1.66231624 |
| 100 | B lymphocytopenia (HP:0010976) | 1.65302134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TSSK6 | 5.75646413 |
| 2 | EIF2AK3 | 3.76618423 |
| 3 | MST4 | 3.73869717 |
| 4 | EIF2AK1 | 3.32061044 |
| 5 | SRPK1 | 3.11111124 |
| 6 | NEK1 | 3.09714214 |
| 7 | BUB1 | 2.74118987 |
| 8 | VRK2 | 2.60804912 |
| 9 | PBK | 2.44304815 |
| 10 | NUAK1 | 2.41683977 |
| 11 | PLK3 | 2.19150661 |
| 12 | MAP3K12 | 2.11440474 |
| 13 | MKNK2 | 2.00540041 |
| 14 | ZAK | 2.00074164 |
| 15 | TXK | 1.97060012 |
| 16 | TTK | 1.91991331 |
| 17 | TRIM28 | 1.90052170 |
| 18 | MKNK1 | 1.72392654 |
| 19 | PLK4 | 1.71407232 |
| 20 | NME1 | 1.64229868 |
| 21 | CDC7 | 1.60381255 |
| 22 | MAP4K2 | 1.59369184 |
| 23 | NME2 | 1.58686677 |
| 24 | TAF1 | 1.57939861 |
| 25 | WNK4 | 1.48301796 |
| 26 | PASK | 1.34583146 |
| 27 | VRK1 | 1.34183414 |
| 28 | WNK3 | 1.32246172 |
| 29 | SIK3 | 1.30109131 |
| 30 | EIF2AK2 | 1.29380665 |
| 31 | GRK1 | 1.24159685 |
| 32 | TLK1 | 1.18700543 |
| 33 | PLK1 | 1.13965893 |
| 34 | BMPR1B | 1.07904462 |
| 35 | ADRBK2 | 1.07240053 |
| 36 | ALK | 1.03417700 |
| 37 | BMPR2 | 1.02105363 |
| 38 | ACVR1B | 0.99389953 |
| 39 | WEE1 | 0.96665321 |
| 40 | STK39 | 0.95821669 |
| 41 | ATR | 0.94096104 |
| 42 | TNIK | 0.92309139 |
| 43 | OXSR1 | 0.92194535 |
| 44 | TEC | 0.89860234 |
| 45 | CDK19 | 0.86817749 |
| 46 | BCKDK | 0.86041807 |
| 47 | STK16 | 0.85971205 |
| 48 | ILK | 0.81470787 |
| 49 | PAK4 | 0.81188220 |
| 50 | CSNK1G3 | 0.79972529 |
| 51 | CSNK1G1 | 0.77354143 |
| 52 | PDK2 | 0.77281043 |
| 53 | FRK | 0.76203434 |
| 54 | MAP2K6 | 0.76047294 |
| 55 | ERBB3 | 0.74276521 |
| 56 | DAPK1 | 0.71523576 |
| 57 | AURKB | 0.70507689 |
| 58 | CSNK1A1L | 0.69914588 |
| 59 | CSNK1G2 | 0.69859205 |
| 60 | FLT3 | 0.65804124 |
| 61 | BCR | 0.63810068 |
| 62 | SCYL2 | 0.63052561 |
| 63 | PHKG1 | 0.62224302 |
| 64 | PHKG2 | 0.62224302 |
| 65 | MYLK | 0.61385949 |
| 66 | TIE1 | 0.59577338 |
| 67 | PLK2 | 0.59042719 |
| 68 | ERBB4 | 0.57237580 |
| 69 | BRSK2 | 0.56093682 |
| 70 | CSNK2A2 | 0.52737939 |
| 71 | ATM | 0.50874241 |
| 72 | CSNK2A1 | 0.50489824 |
| 73 | TGFBR1 | 0.49839728 |
| 74 | CHEK2 | 0.49801162 |
| 75 | CDK8 | 0.48399450 |
| 76 | CSNK1E | 0.46079056 |
| 77 | FGFR1 | 0.45528346 |
| 78 | MAPKAPK5 | 0.44283785 |
| 79 | WNK1 | 0.43276579 |
| 80 | CHEK1 | 0.41836611 |
| 81 | STK3 | 0.40738207 |
| 82 | TAOK3 | 0.37431666 |
| 83 | STK4 | 0.36760229 |
| 84 | CDK7 | 0.36669026 |
| 85 | IKBKB | 0.33559996 |
| 86 | STK10 | 0.30140990 |
| 87 | TESK1 | 0.28820614 |
| 88 | DYRK2 | 0.28102682 |
| 89 | BRSK1 | 0.26712602 |
| 90 | INSRR | 0.24754162 |
| 91 | MAP3K8 | 0.24702585 |
| 92 | PIK3CG | 0.23363441 |
| 93 | MAP3K14 | 0.23148026 |
| 94 | KIT | 0.22416227 |
| 95 | ITK | 0.22275022 |
| 96 | ADRBK1 | 0.21485994 |
| 97 | RPS6KB2 | 0.20967271 |
| 98 | CDK1 | 0.19359405 |
| 99 | CSNK1A1 | 0.18361796 |
| 100 | IGF1R | 0.16889553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.05551856 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.64247276 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.62276791 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.85450173 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.76270166 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.72460227 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.61246832 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.46764267 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.44274415 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.40231594 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.28950977 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.23840852 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.23493000 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.13571125 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 2.11337899 |
| 16 | RNA degradation_Homo sapiens_hsa03018 | 2.11168698 |
| 17 | RNA transport_Homo sapiens_hsa03013 | 2.03036565 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 2.00974505 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.92863720 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.80887144 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.71909579 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.69476877 |
| 23 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.59720354 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55698504 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.53248650 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.51644256 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48282757 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44642692 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43561347 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.42408195 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41913240 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41694030 |
| 33 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.37777500 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.31608240 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23369458 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22929262 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20870592 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.17552977 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16937579 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16692142 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08616073 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06416268 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00145459 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95692335 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90282804 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88190699 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.85710397 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84771576 |
| 49 | Cell cycle_Homo sapiens_hsa04110 | 0.82781661 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79987923 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79468958 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70173442 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68015671 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67367736 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67357184 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65639924 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65252486 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64599421 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64404622 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60264952 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57316790 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54905899 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54783405 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54706421 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54481609 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53178520 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.51543277 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50733460 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48756610 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47953762 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.47569972 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46866702 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46160998 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44769144 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42801020 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41855274 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.41434868 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41057432 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40009728 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.38500569 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38429866 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37410637 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33651933 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32493548 |
| 85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.31290961 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28130039 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26024686 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.25537810 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.23964151 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.23017519 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22950658 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.21569990 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.21440652 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21187364 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.20609057 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.20456416 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.18353412 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15797392 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15249565 |
| 100 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.13816460 |

